Pipeline — registered trials by phase
Extended ECG Monitoring in HCM Patients
— · Hypertrophic Cardiomyopathy, Nonsustained Ventricular Tachycardia, Ventricular Tachycardia · Completed · est. 2022-04-18
Pediatric Adhesion and New Dermal Approach Study
— · Syncope, Pediatric, Congenital Athymia · Completed · est. 2025-09-26
True Continuous ECG Monitoring (TCEM Study)
— · Cardiac Arrhythmia · Completed · est. 2012-11
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
— · Cardiac Arrhythmia · Completed · est. 2025-07-29
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where iRhythm is lead sponsor; 4 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-05Current report (material event)
- 8-K2026-09-22Current report (material event)
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- SCHEDULE 13G2026-08-13SCHEDULE 13G
- 8-K2026-08-13Current report (material event)
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- 8-K2026-08-06Current report (material event)
- 8-K2026-06-15Current report (material event)
- 8-K2026-06-05Current report (material event)
- 8-K2026-05-28Current report (material event)
- S-82026-05-27Employee stock plan
- SCHEDULE 13G2026-05-15SCHEDULE 13G
- SD2026-05-15SD
- SCHEDULE 13G/A2026-05-08SCHEDULE 13G/A
- 10-Q2026-04-30Quarterly report
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-28SCHEDULE 13G
- SCHEDULE 13G2026-04-27SCHEDULE 13G
- DEFA14A2026-04-17DEFA14A
- DEF 14A2026-04-17Proxy statement
- PRE 14A2026-04-06PRE 14A
- 8-K2026-04-01Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- SCHEDULE 13G2026-03-23SCHEDULE 13G
- 8-K2026-03-12Current report (material event)
- 10-K2026-02-19Annual report
- 8-K2026-02-19Current report (material event)
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-03SCHEDULE 13G/A
- 15-12G2026-01-3015-12G
- S-8 POS2026-01-12S-8 POS
- S-8 POS2026-01-12S-8 POS
- S-8 POS2026-01-12S-8 POS
- S-8 POS2026-01-12S-8 POS
- S-8 POS2026-01-12S-8 POS
- S-8 POS2026-01-12S-8 POS
- S-8 POS2026-01-12S-8 POS
- 8-K12B2026-01-128-K12B
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.